NDTP.US NDT Pharmaceuticals Inc
- Market cap
- USD 21.0M
- P/E
- -
- P/B
- 49.36x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is NDTP.US undervalued?
Graham numberThe Graham number of NDT Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
NDT Pharmaceuticals Inc fundamental analysis
No fundamental analysis for NDT Pharmaceuticals Inc yet.
NDT Pharmaceuticals Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About NDT Pharmaceuticals Inc
NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Tulsa, Oklahoma.
Full company profileFinancial statements of NDT Pharmaceuticals Inc are not available yet.
NDT Pharmaceuticals Inc dividends
NDT Pharmaceuticals Inc has not paid dividends in the last 1 fiscal years.
Last stock split: 1:1000 on May 15, 2020.
Who owns NDT Pharmaceuticals Inc
Ownership data of NDT Pharmaceuticals Inc is not available yet.
NDT Pharmaceuticals Inc company profile
- Company name
- NDT Pharmaceuticals Inc
- Ticker
- NDTP.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 1207 Lewis AV, Tulsa, OK, United States, 74104
- Phone
- 888-261-9127
- Website
- ndtpharma.com
About NDT Pharmaceuticals Inc
NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Tulsa, Oklahoma.
NDT Pharmaceuticals Inc management
3- Mr. Robert DeZanger IIIChairman and President
- Mr. James B. HovisActing Chief Executive Officer · born 1950
- Ms. Lisa ZuckTreasurer, Secretary and Director